Named after the final basecamp on the way up Mount Everest, CAMP4 Therapeutics is pioneering a novel gene expression upregulation technology to treating hundreds of diseases affecting millions of patients, such as haploinsufficiencies and recessive or loss-of-function diseases. The company was co-founded by two prominent Boston-area academics, Rick Young, PhD (Whitehead Institute/MIT) and Leonard Zon MD (Boston Children’s Hospital/Harvard Medical School . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge